These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8678582)

  • 1. Whole-body positron emission tomography: an accurate staging modality for metastatic melanoma.
    Böni R
    Arch Dermatol; 1996 Jul; 132(7):833-4. PubMed ID: 8678582
    [No Abstract]   [Full Text] [Related]  

  • 2. Primary staging and follow-up of high risk melanoma patients with whole-body 18F-fluorodeoxyglucose positron emission tomography: results of a prospective study of 100 patients.
    Mijnhout GS; Pijpers R; Hoekstra OS; Teule GJ; Borgstein PJ; Meijer S
    Cancer; 1999 Mar; 85(5):1199-201. PubMed ID: 10091807
    [No Abstract]   [Full Text] [Related]  

  • 3. Malignant melanoma staging using whole-body positron emission tomography.
    Paquet P; Hustinx R; Rigo P; Piérard GE
    Melanoma Res; 1998 Feb; 8(1):59-62. PubMed ID: 9508378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of high-risk melanoma: comparison of [18F]FDG PET and high-dose 67Ga SPET.
    Kalff V; Hicks RJ; Ware RE; Greer B; Binns DS; Hogg A
    Eur J Nucl Med Mol Imaging; 2002 Apr; 29(4):506-15. PubMed ID: 11914889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3'-18F-fluoro-3'-deoxy-L-thymidine: a new tracer for staging metastatic melanoma?
    Cobben DC; Jager PL; Elsinga PH; Maas B; Suurmeijer AJ; Hoekstra HJ
    J Nucl Med; 2003 Dec; 44(12):1927-32. PubMed ID: 14660718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melanoma imaging with highly specific PET probes: ready for prime time?
    Minn H; Vihinen P
    J Nucl Med; 2011 Jan; 52(1):5-7. PubMed ID: 21149485
    [No Abstract]   [Full Text] [Related]  

  • 7. Fluorodeoxyglucose positron emission tomography for melanoma staging: refining the indications.
    Wagner JD
    Ann Surg Oncol; 2006 Apr; 13(4):444-6. PubMed ID: 16491336
    [No Abstract]   [Full Text] [Related]  

  • 8. Fluorodeoxyglucose positron emission tomography fails to detect distant metastases at initial staging of melanoma patients with metastatic involvement of sentinel lymph node.
    Wagner T; Meyer N; Zerdoud S; Julian A; Chevreau C; Payoux P; Courbon F
    Br J Dermatol; 2011 Jun; 164(6):1235-40. PubMed ID: 21332457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Malignant melanoma: diagnostic value of F-18 FDG positron emission tomography].
    Aigner RM; Schwarz T; Richtig E
    Wien Med Wochenschr; 2002; 152(11-12):286-8. PubMed ID: 12138657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staging of metastatic melanoma by whole-body positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose.
    Böni R; Böni RA; Steinert H; Burg G; Buck A; Marincek B; Berthold T; Dummer R; Voellmy D; Ballmer B
    Br J Dermatol; 1995 Apr; 132(4):556-62. PubMed ID: 7748746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positron emission tomography/computed tomography in melanoma.
    Bourgeois AC; Chang TT; Fish LM; Bradley YC
    Radiol Clin North Am; 2013 Sep; 51(5):865-79. PubMed ID: 24010910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positron emission tomography for staging and management of malignant melanoma.
    Prichard RS; Hill AD; Skehan SJ; O'Higgins NJ
    Br J Surg; 2002 Apr; 89(4):389-96. PubMed ID: 11952577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in skin and ocular melanoma].
    Bourguet P;
    Bull Cancer; 2003 Feb; 90 Spec No():S42-6. PubMed ID: 12739335
    [No Abstract]   [Full Text] [Related]  

  • 14. Neoadjuvant Talimogene Laherparepvec for the Treatment of Metastatic Melanoma.
    Stiles ZE; Fleming MD; Luce EA; Deneve JL
    Am Surg; 2017 Jul; 83(7):e266-268. PubMed ID: 28738934
    [No Abstract]   [Full Text] [Related]  

  • 15. Desmoplastic malignant melanoma evaluated with 18F-fluorodeoxyglucose positron emission tomography-computed tomography and sentinel lymph node biopsy.
    Jung JY; Roh MR; Chung HJ; Chung KY
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):126-7. PubMed ID: 18181996
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of Preoperative PET/CT Staging in Sentinel Lymph Node-Positive Melanoma.
    Scheier BY; Lao CD; Kidwell KM; Redman BG
    JAMA Oncol; 2016 Jan; 2(1):136-7. PubMed ID: 26401901
    [No Abstract]   [Full Text] [Related]  

  • 17. Positron emission tomography scanning in malignant melanoma.
    Tyler DS; Onaitis M; Kherani A; Hata A; Nicholson E; Keogan M; Fisher S; Coleman E; Seigler HF
    Cancer; 2000 Sep; 89(5):1019-25. PubMed ID: 10964332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acne masquerading as malignant melanoma on positron emission tomography-computed tomography scan.
    Atanasovski M; Watson AC
    J Am Acad Dermatol; 2013 Sep; 69(3):480. PubMed ID: 23957970
    [No Abstract]   [Full Text] [Related]  

  • 19. Positron emission tomography/computed tomography: use for initial staging of malignant melanoma.
    Harlan E; Davis MD; Pittelkow MR
    Int J Dermatol; 2010 Sep; 49(9):1056-8. PubMed ID: 20883270
    [No Abstract]   [Full Text] [Related]  

  • 20. Detection of metastases in patients with cutaneous melanoma using FDG-PET/CT.
    Akcali C; Zincirkeser S; Erbagcý Z; Akcali A; Halac M; Durak G; Sager S; Sahin E
    J Int Med Res; 2007; 35(4):547-53. PubMed ID: 17697533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.